Search

Your search keyword '"Proto-Oncogene Proteins biosynthesis"' showing total 4,270 results

Search Constraints

Start Over You searched for: Descriptor "Proto-Oncogene Proteins biosynthesis" Remove constraint Descriptor: "Proto-Oncogene Proteins biosynthesis"
4,270 results on '"Proto-Oncogene Proteins biosynthesis"'

Search Results

1. Clinicopathological Significance of AKT1 and PLK1 Expression in Oral Squamous Cell Carcinoma.

2. A review on the role of GAS6 and GAS6-AS1 in the carcinogenesis.

3. Integrated bioinformatics analysis reveals CDK1 and PLK1 as potential therapeutic targets of lung adenocarcinoma.

4. The COP9 signalosome subunit 3 is necessary for early embryo survival by way of a stable protein deposit in mouse oocytes.

5. FZD6 triggers Wnt-signalling driven by WNT10B IVS1 expression and highlights new targets in T-cell acute lymphoblastic leukemia.

6. MiR-706 alleviates white matter injury via downregulating PKCα/MST1/NF-κB pathway after subarachnoid hemorrhage in mice.

7. SNHG10/DDX54/PBX3 Feedback Loop Contributes to Gastric Cancer Cell Growth.

8. Bone marrow-derived AXL tyrosine kinase promotes mitogenic crosstalk and cardiac allograft vasculopathy.

9. Oocyte-secreted factors strongly stimulate sFRP4 expression in human cumulus cells.

10. CPSF4 promotes triple negative breast cancer metastasis by upregulating MDM4.

11. CASK regulates Notch pathway and functions as a tumor promoter in pancreatic cancer.

12. MDM4 as a Prognostic Factor for Patients With Gastric Cancer With Low Expression of p53.

13. High expression of MYEOV reflects poor prognosis in non-small cell lung cancer.

14. MicroRNA-210 downregulates TET2 and contributes to inflammatory response in neonatal hypoxic-ischemic brain injury.

15. In Vitro Production of Perdeuterated Proteins in H 2 O for Biomolecular NMR Studies.

16. Toll‑like receptor 4 activates the NLRP3 inflammasome pathway and periodontal inflammaging by inhibiting Bmi‑1 expression.

17. The long non-coding RNA TSLC8 inhibits colorectal cancer by stabilizing puma .

18. Wingless ligands and beta-catenin expression in the rat endometrium: The role of Wnt3 and Wnt7a/beta-catenin pathway at the embryo-uterine interface.

19. Long non‑coding RNA ZEB2‑AS1 affects cell proliferation and apoptosis via the miR‑122‑5p/PLK1 axis in acute myeloid leukemia.

20. Analyses of expressions and prognostic values of Polo-like kinases in non-small cell lung cancer.

21. CDK9 activity is critical for maintaining MDM4 overexpression in tumor cells.

22. CML - Not only BCR-ABL1 matters.

23. Resveratrol inhibits the tumor migration and invasion by upregulating TET1 and reducing TIMP2/3 methylation in prostate carcinoma cells.

24. Diagnostic Utility of BCOR Antibody in Clear Cell Sarcomas of Kidney.

25. MicroRNA22-5p targets ten-eleven translocation and regulates estrogen receptor 2 expression in infertile women with minimal/mild endometriosis during implantation window.

26. Metformin suppresses the growth of leukemia cells partly through downregulation of AXL receptor tyrosine kinase.

27. Increased Expression of Gankyrin and Stemness Factor Oct-4 are Associated with Unfavorable Clinical Outcomes and Poor Benefit of Tamoxifen in Breast Carcinoma Patients.

28. Novel Mutations and Decreased Expression of the Epigenetic Regulator TET2 in Pulmonary Arterial Hypertension.

29. The Effects of microRNA-515-5p on the Toll-Like Receptor 4 (TLR4)/JNK Signaling Pathway and WNT1-Inducible-Signaling Pathway Protein 1 (WISP-1) Expression in Rheumatoid Arthritis Fibroblast-Like Synovial (RAFLS) Cells Following Treatment with Receptor Activator of Nuclear Factor-kappa-B Ligand (RANKL).

30. Angiotensin II type 1 receptor blockers favorably affect renal angiotensin II and MAS receptor expression in patients with diabetic nephropathy.

31. An energy restriction-based weight loss intervention is able to reverse the effects of obesity on the expression of liver tumor-promoting genes.

32. Activation of CD137 signaling promotes neointimal formation by attenuating TET2 and transferrring from endothelial cell-derived exosomes to vascular smooth muscle cells.

33. Chlorogenic acid inhibits esophageal squamous cell carcinoma growth in vitro and in vivo by downregulating the expression of BMI1 and SOX2.

34. A four-mRNA model to improve the prediction of breast cancer prognosis.

35. Clinicopathological and prognostic implications of polo-like kinase 1 expression in colorectal cancer: A systematic review and meta-analysis.

36. Expression of myeloid Src-family kinases is associated with poor prognosis in AML and influences Flt3-ITD kinase inhibitor acquired resistance.

37. Knockdown of COPS3 inhibits the progress of prostate cancer through reducing phosphorylated p38 MAPK expression and impairs the epithelial-mesenchymal transition process.

38. The role of receptor MAS in microglia-driven retinal vascular development.

39. Intersections and Clinical Translations of Diabetes Mellitus with Cancer Promotion, Progression and Prognosis.

40. Down-regulation of long non-coding RNA SNHG14 protects against acute lung injury induced by lipopolysaccharide through microRNA-34c-3p-dependent inhibition of WISP1.

41. Underlying mechanisms behind the protective effect of angiotensin (1-7) in experimental rat model of ovarian ischemia reperfusion injury.

42. Hematopoietic niche drives FLT3-ITD acute myeloid leukemia resistance to quizartinib via STAT5-and hypoxia-dependent upregulation of AXL.

43. Antiproliferative and toxicogenomic effects of resveratrol in bladder cancer cells with different TP53 status.

44. MDM4 expression in fibrolamellar hepatocellular carcinoma.

45. A combination of LMO2 negative and CD38 positive is useful for the diagnosis of Burkitt lymphoma.

46. Fatty degeneration and wnt10b expression in the supraspinatus muscle after surgical repair of torn rotator cuff tendon.

47. MicroRNA-139 is a predictor of prostate cancer recurrence and inhibits growth and migration of prostate cancer cells through cell cycle arrest and targeting IGF1R and AXL.

48. LncRNA-ANRIL promotes gastric cancer progression by enhancing NF-kB signaling.

49. Aflatoxin B 1 induces S phase arrest by upregulating the expression of p21 via MYC, PLK1 and PLD1.

50. MYC deregulates TET1 and TET2 expression to control global DNA (hydroxy)methylation and gene expression to maintain a neoplastic phenotype in T-ALL.

Catalog

Books, media, physical & digital resources